IP Verse

Formulations Of (+)-2-[1-(3-Ethoxy-4-Methoxy-Phenyl)-2-Methanesulfonyl-Ethyl]-4-Acetyl Aminoisoindoline-1,3-Dione - EP3756650

The patent EP3756650 was granted to Amgen Europe on Aug 20, 2025. The application was originally filed on Dec 26, 2012 under application number EP20172615A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3756650

AMGEN EUROPE
Application Number
EP20172615A
Filing Date
Dec 26, 2012
Status
Granted And Under Opposition
Jul 18, 2025
Publication Date
Aug 20, 2025
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

CAMULONOct 24, 2025REDDIE & GROSE -
ELKINGTON AND FIFEOct 1, 2025ELKINGTON AND FIFE -

Patent Citations (36) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS2002054899
DESCRIPTIONUS2004029832
DESCRIPTIONUS2004087546
DESCRIPTIONUS2004091455
DESCRIPTIONUS2004190609
DESCRIPTIONUS2004220144
DESCRIPTIONUS2005100529
DESCRIPTIONUS2005143344
DESCRIPTIONUS2005143420
DESCRIPTIONUS2005203142
DESCRIPTIONUS2005214328
DESCRIPTIONUS2005222209
DESCRIPTIONUS2005239842
DESCRIPTIONUS2006030594
DESCRIPTIONUS2006122228
DESCRIPTIONUS2006154880
DESCRIPTIONUS2006188475
DESCRIPTIONUS2007048327
DESCRIPTIONUS5632984
DESCRIPTIONUS5635517
DESCRIPTIONUS5770589
DESCRIPTIONUS5800819
DESCRIPTIONUS6001368
DESCRIPTIONUS6015803
DESCRIPTIONUS6218369
DESCRIPTIONUS6225348
DESCRIPTIONUS6281230
DESCRIPTIONUS6962940
DESCRIPTIONWO2004103274
DESCRIPTIONWO2010093588
DESCRIPTIONWO9803502
DESCRIPTIONWO9854170
SEARCHUS2007155791
SEARCHUS6962940
SEARCHWO0104195
SEARCHWO2012083017

Non-Patent Literature (NPL) Citations (7) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
DESCRIPTION- JENS T. CARSTENSEN, Drug Stability: Principles & Practice, Marcel Dekker, (19950000), pages 379 - 80
EXAMINATION- H. VROMANS ET AL., "Studies on tableting properties of lactose", PHARMACEUTISCH WEEKBLAD SCIENTIFIC EDITION, (1985), vol. 7, pages 186 - 193
EXAMINATION- M. C. GOHEL, "A review of co-processed directly compressible excipients", J PHARM PHARMACEUT SCI, (2005), vol. 8, no. 1, pages 76 - 93
EXAMINATION- QIU ET AL., "Kinetic study of the Maillard reaction between metoclopramide hydrochloride and lactose", INT. J. OF PHARMACEUTICS, (2005), vol. 303, pages 20 - 30, XP005080637
OTHER- Rowe Raymond, C Paul J Sheskey; Marian E Quinn, "Handbook of Pharmaceutical Excipients, Sixth Edition /Passage/", Handbook of Pharmaceutical Excipients, (20090101), pages 364 - 369, XP093190639
OTHER- Qiu, Z. Stowell, J.G. Morris, K.R. Byrn, S.R. Pinal, R., "Kinetic study of the Maillard reaction between metoclopramide hydrochloride and lactose", International Journal of Pharmaceutics, NL , (20051013), vol. 303, no. 1-2, doi:10.1016/j.ijpharm.2005.06.016, ISSN 0378-5173, pages 20 - 30, XP005080637
SEARCH- Sonali S. Bharate ET AL, "Interactions and incompatibilities of pharmaceutical excipients with active pharmaceutical ingredients: a comprehensive review", Journal of Excipients and Food Chemicals, (20101230), pages 3 - 26, URL: http://ojs.abo.fi/index.php/jefc/article/view/26, (20200902), XP055131570 [A] 1-17 * page 20 *

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents